April 22, 2019 | Nancy Tyrrell
Accelerator Awards Announced — 2nd Application Round (Spring 2018)
In spring 2018, the CBC has launched a new Accelerator Award program to support translational research and provide university researchers with “early commercial guidance.” Accelerator Awards aim to support the initial, and therefore highest risk, stage of commercially-directed research focused on the development of a therapeutic or an associated biomarker or diagnostic. The program encourages interactions between academic researchers and industry/pharmaceutical experts early in the development of projects and provides advice to award recipients in setting and progressing toward commercialization milestones. Award recipients will be mentored by faculty, industry experts, tech transfer officers and CBC personnel. Accelerator awardees will provide project updates at CBCAN meetings.
The CBC is pleased to announce that four teams received Accelerator Awards in the second application round:
- PI: Tsutomu Kume (NU) for the project:
Potential Treatment of Corneal Vascularization - PI: Shiva Shahrara (UIC) for the project:
Establishing a Novel Therapy for RA Patients - PI: Terry Vanden Hoek (UIC) for the project:
Novel PHLPP Peptide for Asystole/PEA Resuscitation - PI: Gregory Thatcher (UIC) for the project:
A Novel BET Inhibitor for Breast Cancer Combination Therapy
Four winners of the CBC Accelerator Award, application round 2 (Fall 2018).
From the left: Tsutomu Kume, NU, Shiva Shahrara, UIC, Terry Vanden Hoek, UIC and Gregory Thatcher, UIC
See more: